BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21080944)

  • 21. Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia.
    Huang X; Geng S; Weng J; Lu Z; Zeng L; Li M; Deng C; Wu X; Li Y; Du X
    Cancer Cell Int; 2015; 15():93. PubMed ID: 26448723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
    Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
    Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.
    Abbas S; Sanders MA; Zeilemaker A; Geertsma-Kleinekoort WM; Koenders JE; Kavelaars FG; Abbas ZG; Mahamoud S; Chu IW; Hoogenboezem R; Peeters JK; van Drunen E; van Galen J; Beverloo HB; Löwenberg B; Valk PJ
    Haematologica; 2014 May; 99(5):848-57. PubMed ID: 24441149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
    Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
    Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis.
    Gu X; Wang Y; Zhang G; Li W; Tu P
    J Dermatol; 2013 Aug; 40(8):596-605. PubMed ID: 23682716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The oncogenetic landscape and clinical impact of
    Dourthe ME; Andrieu GP; Potier A; Balducci E; Guerder J; Simonin M; Courtois L; Petit A; Macintyre E; Boissel N; Baruchel A; Asnafi V
    Haematologica; 2023 Nov; 108(11):3165-3169. PubMed ID: 36891734
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia.
    Li K; Chen C; Gao R; Yu X; Huang Y; Chen Z; Liu Z; Chen S; Luo G; Huang X; Przybylski GK; Li Y; Zeng C
    Biomark Res; 2021 Mar; 9(1):17. PubMed ID: 33663588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the transcription factor Bcl11b in development and lymphomagenesis.
    Kominami R
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients.
    Karami J; Mahmoudi M; Amirzargar A; Gharshasbi M; Jamshidi A; Aslani S; Nicknam MH
    Genes Immun; 2017 Sep; 18(3):170-175. PubMed ID: 28794504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of Inducible
    Przybylski GK; Korsak D; Iżykowska K; Nowicka K; Zalewski T; Tubacka M; Mosor M; Januszkiewicz-Lewandowska D; Frydrychowicz M; Boruczkowski M; Dworacki G; van den Brandt J; Grabarczyk P; Schmidt CA; Zeng C; Li Y
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after γ-irradiation through Wnt/β-catenin pathway.
    Sakamaki A; Katsuragi Y; Otsuka K; Tomita M; Obata M; Iwasaki T; Abe M; Sato T; Ochiai M; Sakuraba Y; Aoyagi Y; Gondo Y; Sakimura K; Nakagama H; Mishima Y; Kominami R
    Carcinogenesis; 2015 Jun; 36(6):622-31. PubMed ID: 25827435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas.
    Pinkney KA; Jiang W; Lee BJ; Loredan DG; Li C; Bhagat G; Zha S
    J Hematol Oncol; 2015 Jul; 8():94. PubMed ID: 26219558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.
    Grabarczyk P; Nähse V; Delin M; Przybylski G; Depke M; Hildebrandt P; Völker U; Schmidt CA
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancer Hijacking Drives Oncogenic
    Montefiori LE; Bendig S; Gu Z; Chen X; Pölönen P; Ma X; Murison A; Zeng A; Garcia-Prat L; Dickerson K; Iacobucci I; Abdelhamed S; Hiltenbrand R; Mead PE; Mehr CM; Xu B; Cheng Z; Chang TC; Westover T; Ma J; Stengel A; Kimura S; Qu C; Valentine MB; Rashkovan M; Luger S; Litzow MR; Rowe JM; den Boer ML; Wang V; Yin J; Kornblau SM; Hunger SP; Loh ML; Pui CH; Yang W; Crews KR; Roberts KG; Yang JJ; Relling MV; Evans WE; Stock W; Paietta EM; Ferrando AA; Zhang J; Kern W; Haferlach T; Wu G; Dick JE; Klco JM; Haferlach C; Mullighan CG
    Cancer Discov; 2021 Nov; 11(11):2846-2867. PubMed ID: 34103329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis.
    Yu X; Li Y; Yang P; Wang Y; Liu X; Cai L; Lai J; Zhang Y; Zha X; Przybylski GK; Xu L; Li Y
    Clin Transl Med; 2024 Feb; 14(2):e1580. PubMed ID: 38317587
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia.
    Sanghvi VR; Mavrakis KJ; Van der Meulen J; Boice M; Wolfe AL; Carty M; Mohan P; Rondou P; Socci ND; Benoit Y; Taghon T; Van Vlierberghe P; Leslie CS; Speleman F; Wendel HG
    Sci Signal; 2014 Nov; 7(352):ra111. PubMed ID: 25406379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
    Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
    Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis.
    Abe H; Kamimura K; Okuda S; Watanabe Y; Inoue J; Aoyagi Y; Wakai T; Kominami R; Terai S
    Cancer Med; 2023 Jul; 12(14):15650-15663. PubMed ID: 37293953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression ratio as a predictive determinant of nelarabine chemosensitivity in T-lymphoblastic leukemia/lymphoma.
    Sripornsawan P; Okamoto Y; Nishikawa T; Kodama Y; Yamaki Y; Kurauchi K; Tanabe T; Nakagawa S; Shinkoda Y; Imuta N; Kawano Y
    Pediatr Blood Cancer; 2017 Feb; 64(2):250-253. PubMed ID: 27576612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TLX1 oncogene drives aneuploidy in T cell transformation.
    De Keersmaecker K; Real PJ; Gatta GD; Palomero T; Sulis ML; Tosello V; Van Vlierberghe P; Barnes K; Castillo M; Sole X; Hadler M; Lenz J; Aplan PD; Kelliher M; Kee BL; Pandolfi PP; Kappes D; Gounari F; Petrie H; Van der Meulen J; Speleman F; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Soulier J; Avran D; Cavé H; Dastugue N; Raimondi S; Meijerink JP; Cordon-Cardo C; Califano A; Ferrando AA
    Nat Med; 2010 Nov; 16(11):1321-7. PubMed ID: 20972433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.